VIDEO BIOEurope Spring 2019 Themis Bioscience Harnesses Measles Vector For Immune Modulation

VIDEO: BIO-Europe Spring 2019: Themis Bioscience Harnesses Measles Vector For Immune Modulation

03:45 EDT 22 May 2019 | SCRIP

Themis Bioscience CEO Erich Tauber outlined the company’s work in immune modulation in an interview at BIO-Europe Spring 2019.